» Articles » PMID: 33948406

Pulmonary Manifestations of Inflammatory Bowel Disease

Overview
Journal Cureus
Date 2021 May 5
PMID 33948406
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The frequency of extraintestinal manifestations of inflammatory bowel disease (IBD) is observed in most of the patients. Extraintestinal manifestations of IBD have been implicated in all the anatomic sites of the pulmonary tree, and include airway inflammation of the bronchi and bronchioles and parenchymal inflammation. There is a wide range of pulmonary manifestations in IBD, and most of them look a lot like other diseases. Doctors should keep a track of these conditions to avoid unnecessary complications and to provide an early diagnosis with correct and efficient treatment. IBD-related respiratory disorders are treated depending on the patient, but in most of them, steroids are generally chosen first. Steroids, both inhalational and systemic, are the primary approach. Antibiotics could also be given if the patient has infections or suppuration, usually followed by surgeries. However, drug-induced complications and toxicity should be kept in mind.

Citing Articles

Targeted nuclear degranulation of neutrophils promotes the progression of pneumonia in ulcerative colitis.

Shao Y, Zheng Q, Zhang X, Li P, Gao X, Zhang L Precis Clin Med. 2024; 7(4):pbae028.

PMID: 39540022 PMC: 11560370. DOI: 10.1093/pcmedi/pbae028.


Pulmonary Manifestations of IBD: Case Report and Review of the Literature.

Herling A, Perluk T, Freund O, Maharshak N, Cohen N J Clin Med. 2024; 13(18).

PMID: 39336887 PMC: 11432544. DOI: 10.3390/jcm13185401.


Fulminant organizing pneumonia in a patient with ulcerative colitis on mesalamine and infliximab: striving to identify the cause!.

Gomes L, Marques M, Ferreira P J Bras Pneumol. 2023; 49(3):e20220467.

PMID: 37493790 PMC: 10578921. DOI: 10.36416/1806-3756/e20220467.


Organizing Pneumonia and Ulcerative Colitis: A Relationship To Remember.

Pereira Sr S, Sousa D, Esteves A, Constante M, Reis R Cureus. 2023; 15(3):e36396.

PMID: 37090352 PMC: 10114602. DOI: 10.7759/cureus.36396.


The Immune Change of the Lung and Bowel in an Ulcerative Colitis Rat Model and the Protective Effect of Sodium Houttuyfonate Combined With Matrine.

Ni L, Jing S, Zhu L, Yang X, Wang X, Tu S Front Immunol. 2022; 13:888918.

PMID: 35844499 PMC: 9280623. DOI: 10.3389/fimmu.2022.888918.


References
1.
Majewski S, Piotrowski W . Pulmonary manifestations of inflammatory bowel disease. Arch Med Sci. 2016; 11(6):1179-88. PMC: 4697051. DOI: 10.5114/aoms.2015.56343. View

2.
Mahadeva R, Walsh G, Flower C, Shneerson J . Clinical and radiological characteristics of lung disease in inflammatory bowel disease. Eur Respir J. 2000; 15(1):41-8. DOI: 10.1183/09031936.00.15104100. View

3.
Foster R, Zander D, Mergo P, Valentine J . Mesalamine-related lung disease: clinical, radiographic, and pathologic manifestations. Inflamm Bowel Dis. 2003; 9(5):308-15. DOI: 10.1097/00054725-200309000-00004. View

4.
Garber A, Regueiro M . Extraintestinal Manifestations of Inflammatory Bowel Disease: Epidemiology, Etiopathogenesis, and Management. Curr Gastroenterol Rep. 2019; 21(7):31. DOI: 10.1007/s11894-019-0698-1. View

5.
Katsenos S, Psathakis K, Kokkonouzis I, Panagou P, Tsintiris K, Bouros D . Drug-induced pulmonary toxicity in a patient treated with mesalazine and azathioprine for ulcerative colitis. Acta Gastroenterol Belg. 2007; 70(3):290-2. View